David P Schenkein
Director · 1 filing · Latest: Jun 3, 2026
Denali Therapeutics Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
DNLI | David P Schenkein | Director | Jun 3, 2026 | Grant/Award | $0.00 | 6,408 | — | 21,665 |